These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28910204)

  • 1. Chemotherapy-induced neutropenia and the prognosis of colorectal cancer: a meta-analysis of cohort studies.
    Tan X; Wen Q; Wang R; Chen Z
    Expert Rev Anticancer Ther; 2017 Nov; 17(11):1077-1085. PubMed ID: 28910204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study.
    Kasi PM; Kotani D; Cecchini M; Shitara K; Ohtsu A; Ramanathan RK; Hochster HS; Grothey A; Yoshino T
    BMC Cancer; 2016 Jul; 16():467. PubMed ID: 27412464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between neutropenia and prognosis in stage III colorectal cancer patients receiving adjuvant chemotherapy.
    Sunaga T; Suzuki S; Kogo M; Kurihara T; Kaji S; Koike N; Harada N; Suzuki M; Kiuchi Y
    Eur J Cancer Care (Engl); 2014 May; 23(3):394-400. PubMed ID: 24033646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Implications of Chemotherapy-Induced Neutropenia in┬áStage III Colorectal Cancer.
    Kim S; Kang SI; Kim S; Kim JH
    J Surg Res; 2021 Nov; 267():391-396. PubMed ID: 34218138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is microsatellite instability-high really a favorable prognostic factor for advanced colorectal cancer? A meta-analysis.
    Wang B; Li F; Zhou X; Ma Y; Fu W
    World J Surg Oncol; 2019 Oct; 17(1):169. PubMed ID: 31639018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, placebo-controlled phase ii study evaluating the reduction of neutropenia and febrile neutropenia in patients with colorectal cancer receiving pegfilgrastim with every-2-week chemotherapy.
    Hecht JR; Pillai M; Gollard R; Heim W; Swan F; Patel R; Dreiling L; Mo M; Malik I
    Clin Colorectal Cancer; 2010 Apr; 9(2):95-101. PubMed ID: 20378503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of panitumumab in the treatment of patients with metastatic colorectal cancer: a meta-analysis from five randomized controlled trials.
    Liang RF; Zheng LL
    Drug Des Devel Ther; 2015; 9():4471-8. PubMed ID: 26300630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between circulating tumor cells and tumor response in colorectal cancer patients treated with chemotherapy: a meta-analysis.
    Huang X; Gao P; Song Y; Sun J; Chen X; Zhao J; Liu J; Xu H; Wang Z
    BMC Cancer; 2014 Dec; 14():976. PubMed ID: 25519477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
    PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of LINE-1 methylation in predicting survival among colorectal cancer patients: a meta-analysis.
    Ye D; Jiang D; Li Y; Jin M; Chen K
    Int J Clin Oncol; 2017 Aug; 22(4):749-757. PubMed ID: 28343299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of lactate dehydrogenase levels in colorectal cancer: a meta-analysis.
    Li G; Wang Z; Xu J; Wu H; Cai S; He Y
    BMC Cancer; 2016 Mar; 16():249. PubMed ID: 27016045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the impact of the use of granulocyte colony stimulating factors on the incidence of chemotherapy-induced neutropenia in patients with gynecologic malignancies.
    Julius JM; Hammerstrom A; Wei C; Rajesh R; Bodurka DC; Kurian S; Smith JA
    J Oncol Pharm Pract; 2017 Mar; 23(2):121-127. PubMed ID: 26692242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphovascular invasion is a high risk factor for stage I/II colorectal cancer: a systematic review and meta-analysis.
    Yuan H; Dong Q; Zheng B; Hu X; Xu JB; Tu S
    Oncotarget; 2017 Jul; 8(28):46565-46579. PubMed ID: 28430621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials.
    Gargiulo P; Arenare L; Gridelli C; Morabito A; Ciardiello F; Gebbia V; Maione P; Spagnuolo A; Palumbo G; Esposito G; Della Corte CM; Morgillo F; Mancuso G; Di Liello R; Gravina A; Schettino C; Di Maio M; Gallo C; Perrone F; Piccirillo MC
    BMC Cancer; 2021 May; 21(1):549. PubMed ID: 33985435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutropenia predicts better prognosis in patients with metastatic gastric cancer on a combined epirubicin, oxaliplatin and 5-fluorouracil regimen.
    Liu R; Huang M; Zhao X; Peng W; Sun S; Cao J; Ji D; Wang C; Guo W; Li J; Yin J; Zhu X
    Oncotarget; 2015 Nov; 6(36):39018-27. PubMed ID: 26528696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis.
    Sun DW; Zhang YY; Qi Y; Zhou XT; Lv GY
    Cancer Epidemiol; 2015 Apr; 39(2):135-42. PubMed ID: 25677090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-onset neutropenia during perioperative chemotherapy is predictive of increased survival in patients with completely resected non-small cell lung cancer: a retrospective analysis.
    Lee CY; Park SY; Shin TR; Park YB; Kim CH; Jang SH; Lee JW
    Anticancer Res; 2013 Jun; 33(6):2755-61. PubMed ID: 23749937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doublet chemotherapy vs. single-agent therapy with 5FU in elderly patients with metastatic colorectal cancer. a meta-analysis.
    Landre T; Uzzan B; Nicolas P; Aparicio T; Zelek L; Mary F; Taleb C; Des Guetz G
    Int J Colorectal Dis; 2015 Oct; 30(10):1305-10. PubMed ID: 26099322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.
    Rusthoven J; Bramwell V; Stephenson B
    Cancer Prev Control; 1998 Aug; 2(4):179-90. PubMed ID: 10093631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical Resection of Primary Tumor in Asymptomatic or Minimally Symptomatic Patients With Stage IV Colorectal Cancer: A Canadian Province Experience.
    Ahmed S; Fields A; Pahwa P; Chandra-Kanthan S; Zaidi A; Le D; Haider K; Reeder B; Leis A
    Clin Colorectal Cancer; 2015 Dec; 14(4):e41-7. PubMed ID: 26140732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.